EUVIMEDEUVIMED entdecken
Multizentrische Studie

In vitro activity and resistance mechanisms of sulbactam/durlobactam against Acinetobacter baumannii clinical isolates in China (2019–2020)

Qingye Xu, Xiaochen Liu, Haiyang Liu, Siyuan Yang, Tailong Lei, Xiaoting Hua, Yunsong Yu

Clinical Microbiology and Infection · 2026-01 · 32 (1) · 102-109

DOI: 10.1016/j.cmi.2025.09.016 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Microbiology and Infection, 2026-01. Verfasst von Qingye Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Medicine Center, Zhejiang Center for Clinical Laboratory, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical Col…. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Sulbactam, Anti-Bacterial Agents, Acinetobacter Infections. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Medical Science and Technology Project of Zhejiang Province, Ministry of Science and Technology of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiSulbactamAnti-Bacterial AgentsAcinetobacter InfectionsAzabicyclo Compoundsbeta-Lactamase InhibitorsHumansChinaMicrobial Sensitivity TestsWhole Genome SequencingDrug Resistance, Multiple, Bacterial

Stichwörter der Autor:innen

DiazabicyclooctaneNDM metallo-β-lactamasePenicillin-binding proteinsST164β-Lactam/β-lactamase inhibitor

Substanzen

SulbactamAnti-Bacterial AgentsAzabicyclo Compoundsdurlobactambeta-Lactamase Inhibitors

Autor:innen und Institutionen

  • Laboratory Medicine Center, Zhejiang Center for Clinical Laboratory, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Department of Clinical Laboratory, Zhejiang Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China; Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, S…
  • Center for General Practice Medicine, Department of Infectious Diseases, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China. Electronic address: yvys…

Förderung

  • National Natural Science Foundation of China
  • Medical Science and Technology Project of Zhejiang Province
  • Ministry of Science and Technology of the People's Republic of China
  • National Key Research and Development Program of China

Zitieren

APA

Xu, Q., Liu, X., Liu, H., Yang, S., Lei, T., Hua, X., & Yu, Y. (2026). In vitro activity and resistance mechanisms of sulbactam/durlobactam against Acinetobacter baumannii clinical isolates in China (2019–2020). Clinical Microbiology and Infection, 32(1), 102-109. https://doi.org/10.1016/j.cmi.2025.09.016

Vancouver

Xu Q, Liu X, Liu H, Yang S, Lei T, Hua X, et al. In vitro activity and resistance mechanisms of sulbactam/durlobactam against Acinetobacter baumannii clinical isolates in China (2019–2020). Clinical Microbiology and Infection. 2026;32(1):102-109. doi:10.1016/j.cmi.2025.09.016

BibTeX
@article{Xu2026,
  author = {Xu, Qingye and Liu, Xiaochen and Liu, Haiyang and Yang, Siyuan and Lei, Tailong and Hua, Xiaoting and Yu, Yunsong},
  title = {In vitro activity and resistance mechanisms of sulbactam/durlobactam against Acinetobacter baumannii clinical isolates in China (2019–2020)},
  journal = {Clinical Microbiology and Infection},
  year = {2026},
  volume = {32},
  number = {1},
  pages = {102--109},
  doi = {10.1016/j.cmi.2025.09.016}
}
Kostenlos starten →